✦ LIBER ✦

Future options with capecitabine (Xeloda) in (neo)adjuvant treatment of breast cancer

✍ Scribed by Pierre Fumoleau; David Cameron

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of capecitabine (Xeloda

✍ Bruno Reigner; Toru Watanabe; Johannes Schüller; Helen Lucraft; Yasutsuna Sasaki 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 243 KB

PD-0568 PHASE II STUDY OF NEO ADJUVANT T

✍ A. Debucquoy; M. Verstraete; G. Chiritescu; K. Dumon; P. Vergauwe; J.P. Machiels 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 256 KB

446 Quality of life (QoL) in patients wi

✍ G. Segalla; C.T. Oliveira; S. Lago; R. Ribeiro; R. Guimarães; S. Cabral; G. Letc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Neo adjuvant Tamoxifen in post menopausa

✍ R.J Salmon; Y Remvikos; F Campana; O Languille; H Magdalenat; B Asselain; K.B Cl 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Future options in the treatment of ErbB2

✍ Pierre Fumoleau 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Adjuvant Systemic Treatment for Women wi

✍ A. Goldhirsch; R. Gelber 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 157 KB